Role of neutrophils in innate immunity: a systems biology-level approach

被引:193
作者
Kobayashi, Scott D. [1 ]
DeLeo, Frank R. [1 ]
机构
[1] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
基金
美国国家卫生研究院;
关键词
NECROSIS-FACTOR-ALPHA; APOPTOSIS-DIFFERENTIATION PROGRAM; COLONY-STIMULATING FACTOR; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; EARLY TRANSCRIPTIONAL RESPONSE; CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; BINDING-PROTEIN-EPSILON; FACTOR GM-CSF; GENE-EXPRESSION;
D O I
10.1002/wsbm.32
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The innate immune system is the first line of host defense against invading microorganisms. Polymorphonuclear leukocytes (PMNs or neutrophils) are the most abundant leukocyte in humans and essential to the innate immune response against invading pathogens. Compared with the acquired immune response, which requires time to develop and is dependent on previous interaction with specific microbes, the ability of neutrophils to kill microorganisms is immediate, nonspecific, and not dependent on previous exposure to microorganisms. Historically, studies on PMN-pathogen interaction focused on the events leading to killing of microorganisms, such as recruitment/chemotaxis, transmigration, phagocytosis, and activation, whereas post-phagocytosis sequelae were infrequently considered. In addition, it was widely accepted that human neutrophils possessed limited capacity for new gene transcription and thus, relatively little biosynthetic capacity. This notion has changed dramatically within the past decade. Further, there is now more effort directed to understand the events occurring in PMNs after killing of microbes. Herein we review the systems biology-level approaches that have been used to gain an enhanced view of the role of neutrophils during host-pathogen interaction. We anticipate that these and future systems-level studies will ultimately provide information critical to our understanding, treatment, and control of diseases caused by pathogenic microorganisms. (C) 2009 John Wiley & Sons, Inc. WIREs Syst Biol Med 2009 1 309-333
引用
收藏
页码:309 / 333
页数:25
相关论文
共 205 条
[11]   FPRL-1 induces modifications of migration-associated proteins in human neutrophils [J].
Boldt, Karsten ;
Rist, Wolfgang ;
Weiss, Stefanie M. ;
Weith, Andreas ;
Lenter, Martin C. .
PROTEOMICS, 2006, 6 (17) :4790-4799
[12]   Insights into pathogen immune evasion mechanisms:: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils [J].
Borjesson, DL ;
Kobayashi, SD ;
Whitney, AR ;
Voyich, JM ;
Argue, CM ;
DeLeo, FR .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6364-6372
[13]   Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation [J].
Bours, M. J. L. ;
Swennen, E. L. R. ;
Di Virgilio, F. ;
Cronstein, B. N. ;
Dagnelie, P. C. .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (02) :358-404
[14]  
BOXER LA, 1990, BLOOD CELLS, V16, P25
[15]   Interactions between Shiga toxins and human polymorphonuclear leukocytes [J].
Brigotti, Maurizio ;
Carnicelli, Domenica ;
Ravanelli, Elisa ;
Barbieri, Stefania ;
Ricci, Francesca ;
Bontadini, Andrea ;
Tozzi, Alberto E. ;
Scavia, Gaia ;
Caprioli, Alfredo ;
Tazzari, Pier Luigi .
JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (04) :1019-1027
[16]   Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase [J].
Brown, GE ;
Stewart, MQ ;
Bissonnette, SA ;
Elia, AEH ;
Wilker, E ;
Yaffe, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27059-27068
[17]  
Brown SB, 1999, J IMMUNOL, V162, P480
[18]   Maturation of human neutrophil phagosomes includes incorporation of molecular chaperones and endoplasmic reticulum quality control machinery [J].
Burlak, C ;
Whitney, AR ;
Mead, DJ ;
Hackstadt, T ;
DeLeo, FR .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (04) :620-634
[19]   Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection [J].
Carlyon, JA ;
Latif, DA ;
Pypaert, M ;
Lacy, P ;
Fikrig, E .
INFECTION AND IMMUNITY, 2004, 72 (08) :4772-4783
[20]  
Carlyon JA, 2002, J IMMUNOL, V169, P7009, DOI 10.4049/jimmunol.169.12.7009